A recent multicenter study has found that late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) ...

TENS of thousands of Brits are estimated to be unknowingly living with the silent heart condition that nearly killed ...

Midleton man Daniel Ryan has asked members of the public to look out for a navy blue maternity bag - as it contains a child's ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Take hypertrophic cardiomyopathy, or HCM, a primarily genetic condition that results in a thickening of the walls of the heart—specifically its left ventricle, which is the chamber that pumps ...

Patient randomization is underway in SONATA-HCM clinical trial evaluating Lexicon’s novel dual SGLT1 and SGLT2 inhibitor in this underserved and ...

Edgewise Therapeutics (NASDAQ: EWTX) is up 50% in a single session and 450% from recent lows for a reason. Its novel, oral, ...

A bill aimed at preventing the rising number of sudden cardiac arrests among student-athletes would mandate that schools are ...

Shares of biopharma outfit Edgewise Therapeutics ( EWTX -4.14%) soared more than 50% today, reaching a three-year high ...

Rep. Frank Pallone (D-Long Branch)’s Cardiomyopathy Health, Education, Awareness, Research, and Training in Schools (HEARTS) ...

A new analysis from SEQUOIA-HCM showed that treatment with aficamten was associated with beneficial changes in five indices reflecting structural, electrophysiologic and biomarker changes in patients ...

Edgewise Therapeutics announced topline data from Phase 1 and Phase 2 trials of EDG-7500 for obstructive hypertrophic ...